Skip to main content
. 2016 Sep 28;30(6):1765–1779. doi: 10.1111/jvim.14586

Figure 2.

Figure 2

Kaplan‐Meier survival curves plotting the estimated percentage of dogs in each group in the per‐protocol population that have not yet met the primary endpoint (congestive heart failure or cardiac death), against time. There were 178 dogs in the pimobendan group and 176 dogs in the placebo group at the outset. CI, confidence interval; NA, not able to calculate.